HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hansjörg Eibl Selected Research

erucylphospho- N,N,N- trimethylpropylammonium

1/2018Induction of ER and mitochondrial stress by the alkylphosphocholine erufosine in oral squamous cell carcinoma cells.
11/2012Erufosine suppresses breast cancer in vitro and in vivo for its activity on PI3K, c-Raf and Akt proteins.
10/2012Effects of ionizing radiation in combination with Erufosine on T98G glioblastoma xenograft tumours: a study in NMRI nu/nu mice.
8/2002Combination with an antisense oligonucleotide synergistically improves the antileukemic efficacy of erucylphospho-N,N,N-trimethylpropylammonium in chronic myeloid leukemia cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hansjörg Eibl Research Topics

Disease

5Neoplasms (Cancer)
09/2014 - 10/2002
5Glioma (Gliomas)
08/2006 - 09/2002
4Glioblastoma (Glioblastoma Multiforme)
10/2012 - 07/2002
4Brain Neoplasms (Brain Tumor)
12/2004 - 07/2002
2Breast Neoplasms (Breast Cancer)
11/2012 - 12/2003
2Astrocytoma (Pilocytic Astrocytoma)
03/2006 - 07/2002
2Acanthamoeba Keratitis
01/2003 - 03/2002
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2018
1Squamous Cell Carcinoma of Head and Neck
01/2018
1Sarcoma (Soft Tissue Sarcoma)
09/2014
1Body Weight (Weight, Body)
11/2012
1Carcinoma (Carcinomatosis)
11/2012
1Hyperthermia
11/2010
1Leukemia
12/2003
1Lymphoma (Lymphomas)
05/2003
1Corneal Diseases (Corneal Disease)
01/2003
1Necrosis
09/2002
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2002
1Chronic Disease (Chronic Diseases)
03/2002
1Visceral Leishmaniasis (Kala Azar)
03/2002
1Keratitis
03/2002
1Encephalitis (Encephalitis, Rasmussen)
03/2002

Drug/Important Bio-Agent (IBA)

6erucylphosphocholineIBA
08/2006 - 07/2002
5Antineoplastic Agents (Antineoplastics)IBA
11/2012 - 03/2002
4erucylphospho- N,N,N- trimethylpropylammoniumIBA
01/2018 - 08/2002
3Pharmaceutical PreparationsIBA
10/2012 - 10/2002
2Liposomes (Liposome)IBA
09/2014 - 11/2010
2Death Domain ReceptorsIBA
05/2003 - 09/2002
2miltefosine (Impavido)IBA
07/2002 - 03/2002
1GemcitabineFDA Link
09/2014
1pyrimidineIBA
09/2014
1Methylnitrosourea (N-Methyl-N-nitrosourea)IBA
11/2012
1Coloring Agents (Dyes)IBA
11/2012
1Proteins (Proteins, Gene)FDA Link
11/2012
1Estrogen ReceptorsIBA
11/2012
1erucylphosphohomocholine ErPC3IBA
08/2006
1Phosphotransferases (Kinase)IBA
12/2004
11-O-pentylglycerolIBA
12/2003
1Fluorescein (Funduscein)FDA LinkGeneric
12/2003
1Retinoblastoma ProteinIBA
12/2003
1RhodaminesIBA
12/2003
1LigandsIBA
05/2003
1Caspase 3 (Caspase-3)IBA
05/2003
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2003
1Caspase 8 (Caspase-8)IBA
05/2003
1Caspase 9IBA
05/2003
1dibrompropamidineIBA
01/2003
1propamidine isethionateIBA
01/2003
1polihexanideIBA
01/2003
1BradykininIBA
10/2002
1TNF-Related Apoptosis-Inducing LigandIBA
09/2002
1CaspasesIBA
09/2002
1Antisense OligonucleotidesIBA
08/2002

Therapy/Procedure

3Therapeutics
09/2014 - 01/2003
2Contact Lenses
01/2003 - 03/2002
2Drug Therapy (Chemotherapy)
10/2002 - 07/2002
1Subcutaneous Injections
10/2012
1Radiotherapy
10/2012
1Intravenous Injections
03/2006
1Corneal Transplantation (Keratoplasty)
01/2003